Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Salestools Logo

Salestools

L'agente IA #1 per team di vendita e Go-to-Market. Vendi di più, più velocemente, con meno sforzo.

Prodotto

  • Agenti di vendita IA
  • Dati di intenzione
  • Dati Tecnologici
  • Tracciamento Visitatori
  • Co-Pilota
  • Vendita Sociale

Soluzioni

  • Servizio Clienti
  • E-commerce
  • SaaS
  • Impresa
  • Piccole Imprese

Risorse

  • Il rapporto
  • Documentazione
  • Riferimento API
  • Centro assistenza
  • Blog
  • Casi studio
  • Webinar

Azienda

  • Chi siamo
  • Carriere
  • Stampa
  • Contatto
  • Partner

Le nostre sedi

  • New York, HQ
  • Bucarest, Laboratorio di Ricerca IA
  • Zug, Svizzera

© 2025 Salestools. Tutti i diritti riservati.

Termini sui Dati e SicurezzaPolitica sulla privacyTermini di servizio
Tutti i sistemi operativi
Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Back to The Report
Fundraising

C3.ai

C3.ai Raises $125M in Series Unknown

2009
Founded
900+
Employees
1300 Seaport Boulevard, Redwood City, CA 94063
Updated November 16, 2024
2 min read

Quick Facts

C3.ai Raises $125M in Series Unknown


C3.ai has successfully raised $125M in a Series Unknown at a $3B valuation led by TPG Capital, Breyer Capital, Sutter Hill Ventures.


Company Overview


C3.ai is a AI/ML company headquartered in 1300 Seaport Boulevard, Redwood City, CA 94063, founded in 2009 with 900+ employees.


Enterprise AI software


Fundraising Details


  • Amount Raised: $125M
  • Round Type: Series Unknown
  • Valuation: $3B
  • Date: 2024-11-16
  • Investors: TPG Capital, Breyer Capital, Sutter Hill Ventures

About C3.ai


Enterprise AI software The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 1300 Seaport Boulevard, Redwood City, CA 94063
  • Founded: 2009
  • Team Size: 900+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in C3.ai's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. C3.ai's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $3B valuation marks an important milestone for C3.ai, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, C3.ai is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-11-16. For more information about C3.ai, visit their headquarters at 1300 Seaport Boulevard, Redwood City, CA 94063.

Topics

Fundraising(2912)AI/ML(481)Series UnknownC3.ai

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million